Tin tức & Cập nhật
Xem bài viết Sản phụ khoa
Xem
Chỉ hiển thị Multimedia

Temporary ET break for pregnancy safe in the short term for breast cancer survivors
09 May 2023
bởiChristina Lau
Temporary interruption of adjuvant endocrine therapy (ET) to allow for pregnancy has demonstrated short-term safety, with no increase in risk of breast cancer events, including distant recurrence, in hormone receptor–positive breast cancer survivors who have completed 18–30 months of adjuvant ET.
09 May 2023

Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
05 May 2023
bởiAudrey Abella
Good quality surgery conferred a progression-free survival (PFS) benefit for women with ovarian sex cord stromal tumours (SCST) in the first-line setting and on first and second relapse. Chemotherapy, on the other hand, had no impact on survival in the first-line or relapse setting.
05 May 2023






